CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 125 of 1294 entries

View as:

Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689

Phase: N/A Priority: Normal

NCT ID: NCT00623194 Org: User:

Start: 02/29/08 End: 09/30/09 Due: 09/30/10

A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00400283 Org: User:

Start: 01/19/01 End: 05/03/01 Due: 05/03/02

Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects

Phase: N/A Priority: Normal

NCT ID: NCT02235961 Org: User:

Start: 09/04/14 End: 07/06/16 Due: 07/06/17

A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily

Phase: N/A Priority: Normal

NCT ID: NCT01814137 Org: User:

Start: 03/31/13 End: 03/31/14 Due: 03/31/15

A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone

Phase: N/A Priority: Normal

NCT ID: NCT00936403 Org: User:

Start: 08/31/09 End: 07/31/10 Due: 07/31/11

Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00365170 Org: User:

Start: 09/30/02 End: 04/30/05 Due: 04/30/06

Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms

Phase: N/A Priority: Normal

NCT ID: NCT00108849 Org: User:

Start: 03/31/05 End: 05/31/07 Due: 05/31/08

Project to Update the Study of Congenital Haemophilia in Spain

Phase: N/A Priority: Normal

NCT ID: NCT01959555 Org: User:

Start: 03/31/14 End: 12/31/14 Due: 12/31/15

A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Men

Phase: N/A Priority: Normal

NCT ID: NCT04878406 Org: User:

Start: 05/18/21 End: 07/20/21 Due: 07/20/22

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

Phase: N/A Priority: Normal

NCT ID: NCT00872560 Org: User:

Start: 01/20/98 End: 07/27/98 Due: 07/27/99

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00469092 Org: User:

Start: 05/31/07 End: 04/30/08 Due: 04/30/09

Post Marketing Surveillance Study of Biphasic Insulin Aspart 30

Phase: N/A Priority: Normal

NCT ID: NCT01536613 Org: User:

Start: 09/30/04 End: 02/28/07 Due: 02/28/08

Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00841087 Org: User:

Start: 01/31/09 End: 05/31/09 Due: 05/31/10

Effect of Growth Hormone in Children With Growth Hormone Deficiency

Phase: N/A Priority: Normal

NCT ID: NCT00262249 Org: User:

Start: 08/31/00 End: 05/31/04 Due: 05/31/05

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice

Phase: N/A Priority: Normal

NCT ID: NCT05443334 Org: User:

Start: 07/28/22 End: 07/04/24 Due: 07/04/25

Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00592527 Org: User:

Start: 04/30/04 End: 12/31/04 Due: 12/31/05

A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT00951873 Org: User:

Start: 07/31/09 End: 04/30/10 Due: 04/30/11

Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01437592 Org: User:

Start: 09/06/11 End: 11/22/11 Due: 11/22/12

Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00322257 Org: User:

Start: 05/01/06 End: 04/02/08 Due: 04/02/09

Effect of Liraglutide on Heart Frequency in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT01516255 Org: User:

Start: 07/31/06 End: 11/30/06 Due: 11/30/07

Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00613951 Org: User:

Start: 01/31/08 End: 08/31/08 Due: 08/31/09

A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01134224 Org: User:

Start: 05/31/10 End: 11/30/10 Due: 11/30/11

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Korea

Phase: N/A Priority: Normal

NCT ID: NCT00918151 Org: User:

Start: 05/31/09 End: 09/30/09 Due: 09/30/10

A Research Study on Etavopivat in Participants With and Without Liver Disease

Phase: N/A Priority: Normal

NCT ID: NCT06336018 Org: User:

Start: 06/04/24 End: 09/04/25 Due: 09/04/26

A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin Glargine

Phase: N/A Priority: Normal

NCT ID: NCT01704417 Org: User:

Start: 10/31/12 End: 03/31/13 Due: 03/31/14

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689	NCT00623194	Novo Nordisk A/S	user2@example.com	None	2008-02-29	2009-09-30	2010-09-30	-	-	2025-07-14
A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes	NCT00400283	Novo Nordisk A/S	user2@example.com	None	2001-01-19	2001-05-03	2002-05-03	-	-	2025-07-14
Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects	NCT02235961	Novo Nordisk A/S	user2@example.com	None	2014-09-04	2016-07-06	2017-07-06	-	-	2025-07-14
A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily	NCT01814137	Novo Nordisk A/S	user2@example.com	None	2013-03-31	2014-03-31	2015-03-31	-	-	2025-07-14
A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone	NCT00936403	Novo Nordisk A/S	user2@example.com	None	2009-08-31	2010-07-31	2011-07-31	-	-	2025-07-14
Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes	NCT00365170	Novo Nordisk A/S	user2@example.com	None	2002-09-30	2005-04-30	2006-04-30	-	-	2025-07-14
Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms	NCT00108849	Novo Nordisk A/S	user2@example.com	None	2005-03-31	2007-05-31	2008-05-31	-	-	2025-07-14
Project to Update the Study of Congenital Haemophilia in Spain	NCT01959555	Novo Nordisk A/S	user2@example.com	None	2014-03-31	2014-12-31	2015-12-31	-	-	2025-07-14
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Men	NCT04878406	Novo Nordisk A/S	user2@example.com	None	2021-05-18	2021-07-20	2022-07-20	-	-	2025-07-14
Comparison of 2 NovoFine® Needles on the Reflux of Insulin	NCT00872560	Novo Nordisk A/S	user2@example.com	None	1998-01-20	1998-07-27	1999-07-27	-	-	2025-07-14
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes	NCT00469092	Novo Nordisk A/S	user2@example.com	None	2007-05-31	2008-04-30	2009-04-30	-	-	2025-07-14
Post Marketing Surveillance Study of Biphasic Insulin Aspart 30	NCT01536613	Novo Nordisk A/S	user2@example.com	None	2004-09-30	2007-02-28	2008-02-28	-	-	2025-07-14
Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes	NCT00841087	Novo Nordisk A/S	user2@example.com	None	2009-01-31	2009-05-31	2010-05-31	-	-	2025-07-14
Effect of Growth Hormone in Children With Growth Hormone Deficiency	NCT00262249	Novo Nordisk A/S	user2@example.com	None	2000-08-31	2004-05-31	2005-05-31	-	-	2025-07-14
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice	NCT05443334	Novo Nordisk A/S	user2@example.com	None	2022-07-28	2024-07-04	2025-07-04	-	-	2025-07-14
Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes	NCT00592527	Novo Nordisk A/S	user2@example.com	None	2004-04-30	2004-12-31	2005-12-31	-	-	2025-07-14
A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers	NCT00951873	Novo Nordisk A/S	user2@example.com	None	2009-07-31	2010-04-30	2011-04-30	-	-	2025-07-14
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects	NCT01437592	Novo Nordisk A/S	user2@example.com	None	2011-09-06	2011-11-22	2012-11-22	-	-	2025-07-14
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes	NCT00322257	Novo Nordisk A/S	user2@example.com	None	2006-05-01	2008-04-02	2009-04-02	-	-	2025-07-14
Effect of Liraglutide on Heart Frequency in Healthy Volunteers	NCT01516255	Novo Nordisk A/S	user2@example.com	None	2006-07-31	2006-11-30	2007-11-30	-	-	2025-07-14
Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes	NCT00613951	Novo Nordisk A/S	user2@example.com	None	2008-01-31	2008-08-31	2009-08-31	-	-	2025-07-14
A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes	NCT01134224	Novo Nordisk A/S	user2@example.com	None	2010-05-31	2010-11-30	2011-11-30	-	-	2025-07-14
A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Korea	NCT00918151	Novo Nordisk A/S	user2@example.com	None	2009-05-31	2009-09-30	2010-09-30	-	-	2025-07-14
A Research Study on Etavopivat in Participants With and Without Liver Disease	NCT06336018	Novo Nordisk A/S	user2@example.com	None	2024-06-04	2025-09-04	2026-09-04	-	-	2025-07-14
A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin Glargine	NCT01704417	Novo Nordisk A/S	user2@example.com	None	2012-10-31	2013-03-31	2014-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance